Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.11/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Foreign exchange (losses)/gains: 51K
Today's EPS Names:
CABO, CTSO, KPTI, More
Financial Fact:
Foreign exchange (losses)/gains: 51K
Today's EPS Names:
CABO, CTSO, KPTI, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.11), versus ($0.18) reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Forum Energy Technologies (FET) Tops Q3 EPS by 29c ; Offers Guidance
- CareDx, Inc (CDNA) PT Raised to $92 at BTIG
- WEC Energy Group (WEC) PT Raised to $130 at BTIG
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
